- Home
- KAVL vs XAIR Comparison
KAVL vs XAIR Comparison
Compare KAVL & XAIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KAVL | XAIR |
|---|---|---|
| Founded | 1998 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.6M | 10.5M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | KAVL | XAIR |
|---|---|---|
| Price | $0.47 | $1.15 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $11.00 |
| AVG Volume (30 Days) | 62.5K | ★ 1.2M |
| Earning Date | 09-16-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $1,127,037.00 | ★ $5,802,000.00 |
| Revenue This Year | N/A | $128.45 |
| Revenue Next Year | N/A | $153.25 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 147.74 |
| 52 Week Low | $0.40 | $1.14 |
| 52 Week High | $1.55 | $11.20 |
Technical Indicators
Market Signals| Indicator | KAVL | XAIR |
|---|---|---|
| Relative Strength Index (RSI) | 41.41 | 27.57 |
| Support Level | $0.46 | $1.19 |
| Resistance Level | $0.50 | $1.38 |
| Average True Range (ATR) | 0.04 | 0.10 |
| MACD | 0.00 | 0.01 |
| Stochastic Oscillator | 15.60 | 2.94 |
Price Performance
Historical ComparisonAbout KAVL Kaival Brands Innovations Group Inc.
Kaival Brands Innovations Group Inc is focused on growing and incubating creative and profitable products. The company is engaged in the sale, marketing and distribution of electronic nicotine delivery system (ENDS) products and related components. Its primary product includes Bidi Stick. The BIDI Stick comes in a variety of flavor options for adult cigarette smokers.
About XAIR Beyond Air Inc.
Beyond Air Inc is a commercial-stage medical device and biopharmaceutical company that develops a Nitric Oxide (NO) Generator and Delivery System that uses NO generated from ambient air and delivers precise amounts of NO to the lungs for the potential treatment of respiratory and other diseases. The firm is applying its therapeutic expertise to develop treatments for pulmonary hypertension, in addition to treatments for lower respiratory tract infections.